Steroid-Induced Ocular Hypertension in Mice Is Differentially Reduced by Selective EP2, EP3, EP4, and IP Prostanoid Receptor Agonists

Affiliations

Ophthalmology Innovation Center, Santen Inc., Emeryville, 94608, CA, United States; Institute of Ophthalmology, University College London (UCL), London, EC1V 9EL, United Kingdom; Department of Ophthalmology, Imperial College of Science and Technology, St. Mary’s Campus, London, W2 1PG, United Kingdom; Department of Ophthalmology, Eye-ACP Duke-National University of Singapore Medical School, Singapore, 119228, Singapore; Singapore Eye Research Institute (SERI), Singapore, 168751, Singapore; Department of Pharmacy Sciences, Creighton University, Omaha, 68178, NE, United States; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, 77004, TX, United States; Department of Pharmacology & Neuroscience, North Texas Eye Research Institute (NTERI), University of North Texas Health Science Center, Fort Worth, 76107, TX, United States; Department of Ophthalmology and Center for Translational Vision Research, University of California, Irvine, 92617, CA, United States; Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd., Nara, 630-0101, Japan